Viktor Todorovic is a Principal Research Scientist II at AbbVie with extensive experience in immunology drug discovery, focusing on innovative methods to address chronic inflammatory diseases. At AbbVie since July 2014, Viktor has co-led an early target program and significantly contributed to the development and implementation of various in vitro assays, including TR-FRET and Glyco-FRET assays. Previously, Viktor served as a postdoctoral research fellow at Northwestern University's Feinberg School of Medicine, where research involved analyzing desmosomal Armadillo family members in cell-extracellular matrix interactions and their implications for keratinocyte behavior. Viktor holds a Ph.D. in Molecular Genetics from the University of Illinois Chicago and a B.Sc. in Molecular Biology and Physiology from the University of Belgrade.
This person is not in the org chart
This person is not in any teams
This person is not in any offices